Neovascular Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Neovascular Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
This clinical trial update describes the completion of an observational study comparing the rate and extent of intraocular inflammation afte…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration [Phase 3]
Phase 3 clinical trial update on a combination of ranibizumab and verteporfin for neovascular age-related macular degeneration; the study st…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration [Phase 1, Phase 2]
A Phase 1/2 trial comparing ocular pain and inflammation after injections of Lucentis (ranibizumab) versus Eylea (aflibercept) in neovascula…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration. [Phase 4]
This is a Phase 4 clinical trial update evaluating aflibercept (EYLEA) as secondary or third-line treatment for neovascular age-related macu…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) [Phase 1]
Regeneron reports the completion of a Phase 1 study evaluating intravitreal REGN910-3 and REGN910 for neovascular age-related macular degene…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection [Phase 4]
Phase 4 trial update indicates termination of the SENSIMED Triggerfish study involving intraocular anti-VEGF injections for neovascular age-…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD) [Phase 2]
A Phase 2 clinical trial evaluated the efficacy and safety of squalamine lactate eye drops in subjects with neovascular age-related macular …
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Treatment -Resistant Neovascular Age-Related Macular Degeneration [Phase 1]
A Phase 1 study evaluating a treatment for treatment-resistant neovascular age-related macular degeneration has completed. The sponsor is Wa…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone [Phase 3]
A Phase 3 trial investigated retinal effects of combining photodynamic therapy with intravitreal Triamcinolone for neovascular age-related m…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD) [Phase 3]
Open-label extension study of intravitreal aflibercept (EYLEA) in neovascular age-related macular degeneration completed; results were poste…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD [Phase 1]
Phase 1 study evaluating the safety and tolerability of intravitreal VEGF-Trap (aflibercept) in patients with neovascular age-related macula…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD) [Phase 1]
Phase 1 clinical trial reports preliminary safety and efficacy results for PDS-1.0 in patients with neovascular age-related macular degenera…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion [NA]
Clinical trial update reporting a completed study of intravitreal ranibizumab for neovascular age-related macular degeneration with posterio…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD [Phase 2]
This update reports the completion of a Phase 2 randomized, double-masked trial evaluating intravitreal KH902 for neovascular age-related ma…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion [Phase 2]
Phase 2 trial evaluating safety and efficacy of intravitreal ocriplasmin in subjects with exudative age-related macular degeneration and foc…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab [Phase 4]
Phase 4 clinical trial assessing indocyanine green angiography changes in choroidal neovascularization during ranibizumab treatment for exud…
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of KH902 injected intravitreally for neovascular age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration [NA]
Long-term results from a completed trial evaluating intravitreal bevacizumab for neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
This clinical trial update reports ocular safety findings for patients receiving Macugen (pegaptanib) for neovascular age-related macular de…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy [Phase 1]
A Phase 1 trial of an anti-VEGFR vaccine therapy for neovascular age-related macular degeneration (neovascular maculopathy) has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population
A population-based study in China examining choroidal neovascularization in geographic atrophy and wet age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD [Phase 2]
An update on a Phase 2 trial evaluating an OCT-guided, variable dosing regimen of ranibizumab for neovascular age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2012-04-12Clinical Trial Update: Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating Lucentis (ranibizumab) for age-related macular degeneration with pigment epithelial de…
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.
A completed real-world study evaluating the efficacy and safety of Macugen (pegaptanib) for neovascular age-related macular degeneration in …
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study [Phase 3]
Phase 3 trial evaluating ranibizumab plus transpupillary thermotherapy for neovascular age-related macular degeneration has completed.